All Qualifying Conditions for Medical THC in Texas
- A-C
-
A
- Adenylosuccinate synthase Deficiency
- Alexander disease
- Alpers-Huttenlocher syndrome
- ALS (Amyotrophic Lateral Sclerosis)
- Alzheimer's Disease and other dementias
- Amyloidoses
- Argyrophilic Grain Disease
- Aromatic L-amino acid decarboxylase deficiency
- Asparylglucosaminuria
- Ataxia neuropathy spectrum
- Autism and other spectrum disorders
B
- Bidirectional enzyme deficiency
- Biopterin Defects
C
- Canavan disease
- Cancer
- Central Core
- Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy
- Cerebral Palsy
- Charcot Marie Tooth and related hereditary neuropathies
- Childhood Myocerebrohepatopathy spectrum
- Congenital Disorders of Glycosylation
- Corticobasal Degeneration
- Creatine Disorders
- Creatine Transporter Defect, also known as SLC 6A8
- Creutzfeldt-Jakob Disease
- CTE (Chronic Traumatic Encephalopathy)
- D-F
-
D
- Dementia with Lewy Bodies
- Deoxyguanisine kinase deficiency
- Dihydropirimidinase Deficiency
- Dihydropteridine reductase
- Dihydropyrimidine dehydrogenase Deficiency
- Duchenne Muscular Dystrophy
E
- Epilepsy
F
- Facioscapulohumeral Muscular Dystrophy
- Familial or Sporadic Fatal Insomnia
- Familial Spastic Paraplegia
- Farber Disease
- Fatty Acid Oxidation
- Freidreich’s Ataxia
- Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene
- Frontotemporal Lobar Degeneration
- G-I
-
G
- Galactosemia
- Galactosialidosis
- Gaucher Type 2 and Type 3
- Gerstmann-Straussler-Scheinker Disease
- Globular Glial Tauopathy
- Glutaric acidemia type 1
- Glycine encephalopathy, also known as non-ketotic hyperglycinemia
- Glycogen Storage-Lysosomal: Pompe Disease
- GM1 gangliosidosis
- GM2 gangliosidosis also known as Tay-sachs and Sandhoff Disease
- Guanidinoacetate methytransferase deficiency
- Guanosine triphosphate cyclohydrolase deficiency
H
- Homocysteine re-methylation defects
- Huntington's Disease
- Hypoxanthine-guanine phosophoribosyltransferase Deficiency also known as Lesch-Nyhan disease
- J-L
-
K
- Kearn Sayers Syndrome
- Krabbe
- Kuru
L
- L-2-hydroxyglutaric aciduria
- L-Arginine/glycine amidinotransferase deficiency
- Leukodystrophy
- Lewy Body Disorders
- Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency
- Lysosomal Storage Diseases
- M-O
-
M
- Mannosidosis
- Manosidosis alpha and beta
- Maple Syrup Urine Disease
- Metachromatic leukodystrophy
- Metal Metabolism
- Methylenetetrahydrofolate reductase deficiency severe variant
- Mitochondrial Conditions
- Mitochondrial Depletion syndromes types 1 through 14
- Mitochondrial Encephalopathy Lactic Acidosis Stroke
- Mitochondrial Encephalopathy Ragged Red Fiber
- Mitochondrial neurogastrointestinal encephalopathy
- Monoamine oxidase deficiency
- Motor Neuron Disease
- MS (Multiple Sclerosis)
- Mucolipidoses
- Mucolipidoses Type II, also known as Inclusion Cell disease
- Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy
- Mucopolysaccaridosis
- Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome
- Mucopolysaccharidosis Type II, also known as Hunter Syndrome
- Mucopolysaccharidosis Type III, also known as Sanfilippo A and B
- Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy
- Mucopolysaccharidosis Type VII, also known as Sly
- Multiple Sulfatase deficiency
- Multiple System Atrophy
- Muscular Dystrophies
- Myoclonic epilepsy myopathy sensory ataxia
N
- Neimann Pick Type A and B
- Neimann Pick Type C
- Neonatal Adrenoleukodystrophy
- Neurodegeneration with brain iron accumulation
- Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy
- Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease
- Neuropathy, Ataxia, and Retinitis Pigmentosa
- Neurotransmitter defects
O
- Oligosaccharidoses
- P-R
-
P
- S-U
-
S
- V-Z
-
V